Harvard Apparatus Regenerative Technology, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Harvard Apparatus Regenerative Technology, Inc. | |
| By: | /s/ Junli (Jerry) He |
| Junli (Jerry) He | |
| Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| Signature | Title | Date |
|---|---|---|
| /s/ Junli (Jerry) He | Chief Executive Officer, Director, and Chairman | |
| Junli (Jerry) He | (principal executive officer) | March 31, 2025 |
| /s/ Joseph Damasio Jr. | Chief Financial Officer | |
| Joseph Damasio Jr. | (principal financial officer and principal accounting officer) | March 31, 2025 |
| /s/ Jason Jing Chen | ||
| Jason Jing Chen | Vice Chairman | March 31, 2025 |
| /s/ David Green | ||
| David Green | Director | March 31, 2025 |
| /s/ Ting Li | ||
| Ting Li | Director | March 31, 2025 |
| /s/ Ronald Packard | ||
| Ronald Packard | Director | March 31, 2025 |
| /s/ Herman Sanchez | ||
| Herman Sanchez | Director | March 31, 2025 |
| /s/ James Shmerling | ||
| James Shmerling | Director | March 31, 2025 |
| /s/ Mao Zhang | ||
| Mao Zhang | Director | March 31, 2025 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.